Bruker (BRKR) Non-Current Debt (2010 - 2026)
Bruker (BRKR) posted Non-Current Debt of $1.7 billion for Q1 2026, down 10.23% on a QoQ basis from $1.9 billion in Q4 2025, and down 19.9% year-over-year from $2.1 billion in Q1 2025.
Bruker (BRKR) Non-Current Debt (2010 - 2026) Analysis & Trends
Bruker's Non-Current Debt history runs 17 years deep, the most recent figure standing at $1.7 billion for Q1 2026.
- Quarterly Non-Current Debt fell 19.9% year-over-year to $1.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 billion (down 19.9% YoY) and the FY2025 annual result came in at $1.9 billion, down 10.15% from the prior year.
- Non-Current Debt was $1.7 billion for Q1 2026 at Bruker, down from $1.9 billion in the prior quarter.
- Across five years, Non-Current Debt topped out at $2.4 billion in Q2 2025 and bottomed at $1.1 billion in Q3 2023.
- A 5-year average of $1.6 billion and a median of $1.4 billion in 2024 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2024 — Non-Current Debt surged 106.13% — and 2026, when it dropped 19.9%.
- Bruker's Non-Current Debt stood at $1.2 billion in 2022, then decreased by 3.35% to $1.2 billion in 2023, then surged by 77.7% to $2.1 billion in 2024, then decreased by 10.15% to $1.9 billion in 2025, then decreased by 10.23% to $1.7 billion in 2026.
- Business Quant data shows BRKR's Non-Current Debt at $1.7 billion in Q1 2026, $1.9 billion in Q4 2025, and $2.0 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.18 Bn |
| 10 | Bruker | 9.46 Bn | 9.50 Bn | 379.80 Mn | 1.66 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.66 Bn |
| Dec 31, 2025 | 1.85 Bn |
| Sep 30, 2025 | 1.98 Bn |
| Jun 30, 2025 | 2.38 Bn |
| Mar 31, 2025 | 2.08 Bn |
| Dec 31, 2024 | 2.06 Bn |
| Sep 30, 2024 | 2.26 Bn |
| Jun 30, 2024 | 2.13 Bn |
| Mar 31, 2024 | 1.36 Bn |
| Dec 31, 2023 | 1.16 Bn |
| Sep 30, 2023 | 1.10 Bn |
| Jun 30, 2023 | 1.12 Bn |
| Mar 31, 2023 | 1.11 Bn |
| Dec 31, 2022 | 1.20 Bn |
| Sep 30, 2022 | 1.14 Bn |
| Jun 30, 2022 | 1.17 Bn |
| Mar 31, 2022 | 1.21 Bn |
| Dec 31, 2021 | 1.22 Bn |
| Sep 30, 2021 | 717.50 Mn |
| Jun 30, 2021 | 829.30 Mn |